Literature DB >> 7241049

Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.

M A Horwitz, S C Silverstein.   

Abstract

In an accompanying paper (13), we reported that human polymorphonuclear leukocytes kill only a limited proportion (0.5 log) of an inoculum of Legionella pneumophila (Philadelphia 1 strain) in the presence of human anti-L. pneumophila antibody and complement. We now report on the effect of anti-L. pneumophila antibody on L. pneumophila-monocyte interaction. The studies were carried out under antibiotic-free conditions. Monocytes bind more than three times as many viable L. pneumophila bacteria in the presence of both antibody and complement than in the presence of complement alone. Monocytes requires both antibody and complement to kill any L. pneumophila: however, even then, monocytes kill only a limited proportion (0.25 log) of an inoculum. The surviving bacteria multiply several logs in the monocytes and multiply as rapidly as when the bacteria enter monocytes in the absence of antibody. These findings suggest that humoral immunity may not be an effective host defense against L. pneumophila. Consequently, a vaccine that resulted only in antibody production against the Legionnaires' disease bacterium may not be efficacious.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241049      PMCID: PMC2186075          DOI: 10.1084/jem.153.2.398

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Passive transfer of resistance to tuberculosis through use of monocytes.

Authors:  J L SEVER
Journal:  Proc Soc Exp Biol Med       Date:  1960-02

2.  The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii.

Authors:  J L Krahenbuhl; J Ruskin; J S Remington
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

3.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

4.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

6.  Studies on tubercle bacillus-monocyte relationship. III. Conditions affecting the action of serum and cells; modification of bacilli in an immune system.

Authors:  J FONG; D CHIN; H J AKIYAMA; S S ELBERG
Journal:  J Exp Med       Date:  1959-06-01       Impact factor: 14.307

7.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

8.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

9.  Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  THE PASSIVE TRANSFER OF ACQUIRED RESISTANCE TO LISTERIA MONOCYTOGENES.

Authors:  K MIKI; G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  50 in total

1.  Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.

Authors:  J D Cirillo; S L Cirillo; L Yan; L E Bermudez; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Legionella pneumophila entry gene rtxA is involved in virulence.

Authors:  S L Cirillo; L E Bermudez; S H El-Etr; G E Duhamel; J D Cirillo
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Postantibiotic effect of various antibiotics on Legionella pneumophila strains isolated from water systems.

Authors:  Ayşe Seher Birteksöz-Tan; Zuhal Zeybek
Journal:  Folia Microbiol (Praha)       Date:  2012-05-25       Impact factor: 2.099

Review 4.  Amoebae as training grounds for intracellular bacterial pathogens.

Authors:  Maëlle Molmeret; Matthias Horn; Michael Wagner; Marina Santic; Yousef Abu Kwaik
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

Review 5.  Virulence factors of the family Legionellaceae.

Authors:  J N Dowling; A K Saha; R H Glew
Journal:  Microbiol Rev       Date:  1992-03

6.  The effect of oxygen-dependent antimicrobial systems on strains of Legionella pneumophila of different virulence.

Authors:  R I Jepras; R B Fitzgeorge
Journal:  J Hyg (Lond)       Date:  1986-08

7.  Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila.

Authors:  J A Elliott; W C Winn
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Potential virulence role of the Legionella pneumophila ptsP ortholog.

Authors:  F Higa; P H Edelstein
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

9.  Interaction of primate alveolar macrophages and Legionella pneumophila.

Authors:  R F Jacobs; R M Locksley; C B Wilson; J E Haas; S J Klebanoff
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Chemical genetics reveals bacterial and host cell functions critical for type IV effector translocation by Legionella pneumophila.

Authors:  Xavier Charpentier; Joëlle E Gabay; Moraima Reyes; Jing W Zhu; Arthur Weiss; Howard A Shuman
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.